Azurette Kit
Product Images NDC 75907-091

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Azurette (NDC 75907-091). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy�s Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure2 (Fig2)

A forest plot illustrating effect estimates from various women's health studies comparing combined oral contraceptive (COC) use versus never use and current COC use versus never use. The plot shows odds ratios, risk ratios, and hazard ratios with confidence intervals for each study, aligned along an effect estimate axis ranging from -1.50 to 2.00.*

FDA Label Image

Table1 (Table1)

A data table presenting mean pharmacokinetic parameters for desogestrel/ethinyl estradiol and ethinyl estradiol tablets over a 28-day dosing period in the third cycle with 17 participants. Parameters include dose in mg, Cmax (pg/mL), Tmax (hours), half-life (t1/2, hours), AUC0-24 (pg/mL*hr), and clearance (CL/F, L/h) for both etonogestrel and ethinyl estradiol on specified days.*

FDA Label Image

Table2 (Table2)

A data table presenting the percentage of women experiencing unintended pregnancy during the first year of typical use and perfect use of various contraceptive methods, along with the percentage of women continuing use at one year, based on data from the United States. Methods include chance, spermicides, periodic abstinence, withdrawal, barrier methods (cap, sponge, diaphragm, condom), pill types, IUD types, Depo-Provera, Norplant, and sterilization.*

FDA Label Image

Carton (Carton(1))

Packaging label for Azurette kit containing desogestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP in strengths of 0.15 mg/0.02 mg and 0.01 mg. The label indicates the product is for prescription use, distributed by Dr. Reddy's Laboratories Inc., and includes directions about storage and child safety. It also features NDC number 75907-091 and barcode.*

FDA Label Image

Figure1 (Figure1)

Bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman-Years by Age, Smoking Status, and Oral Contraceptive Use.' It compares mortality rates for age groups 15-24, 25-34, 35-44, and 45+, broken down into four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). Mortality rates are shown on the vertical axis as number of deaths per 100,000 woman-years.*

FDA Label Image

Logo (Logo)

FDA Label Image

Picture1 (Picture1)

An illustrated example of a 28-tablet blister card for Azurette, a kit containing desogestrel/ethinyl estradiol and ethinyl estradiol. It shows the weekly tablet arrangement with dark blue tablets for the first three weeks, followed by white and green tablets in the fourth week. The diagram labels days of the week and provides storage and usage instructions on the card.*

FDA Label Image

Picture2 (Picture2)

Illustration showing instructions for applying a day label strip to an Azurette oral contraceptive pill kit blister pack. The diagram includes a hand peeling a day label and positioning it over the pack, which shows the placement area and pill arrangement by weeks and colors (dark blue, white, green).*

FDA Label Image

Structure (Structure)

Chemical structure diagram showing the molecular formulas of desogestrel and ethinyl estradiol. Desogestrel is depicted with the formula C22H30O, and ethinyl estradiol with C20H24O2.*

FDA Label Image

Table3 (Table3)

A data table titled 'Annual number of birth-related or method-related deaths associated with control of fertility per 100,000 non-sterile women, by fertility control method according to age.' It lists different fertility control methods and outcomes across age groups 15-19 through 40-44, showing death rates for no fertility control methods, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with explanatory notes on death types.*

FDA Label Image

Table4 (Table4)

A data table showing the annual number of birth-related or method-related deaths per 100,000 non-sterile women by fertility control method across different age groups (15 to 44). Methods include no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates varying by age and method.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.